Blog

BRUSSELS, BE / ACCESS Newswire / July 22, 2025 / Mediagenix, a global leader in smart content solutions to profitably connect the right content to the right audience, has been named an IDC Innovator in the IDC Innovators: Media and Entertainment 2025* report. According to the report, “Mediagenix positions itself as the global provider in smart content solutions to profitably connect the right content to the right audience. Its modular SaaS platform orchestrates the entire content life cycle to actively drive content lifetime value and audience engagement. Content strategy, content value management, content scheduling, and content personalization all converge into one lean, company-wide collaborative flow revolving around one source of truth. This ‘unified’ approach to the content life cycle makes it unique in the industry.”

According to IDC, “IDC Innovators for 2025 have one common main objective in mind: to provide their customers high-value workflow efficiencies and return on investment.” The IDC Innovators report noted three key differentiators for Mediagenix: AI Integration, Efficiency Gains, and Differentiated Content Life-Cycle Workflow Solution.

“Mediagenix exemplifies innovation in media operations with its unified, AI-powered approach to content strategy, scheduling automation, and intelligent discovery,” said Alex Holtz, Research Director, Worldwide Media and Entertainment Digital Strategies at IDC. “By integrating tools like Human Semantic Search and Smart Content Pool into a modular SaaS platform, Mediagenix delivers a differentiated, end-to-end content life-cycle solution that boosts efficiency, accelerates time-to-air, and improves audience engagement. In a market where media companies struggle with automation and system connectivity, and where rapid cloud adoption adds operational complexity, Mediagenix enables seamless orchestration across multiple platform distributions, helping media companies confidently navigate transformation with minimal disruption.”

Personalization is a Strategic Driver

Unlike traditional personalization approaches that focus on the front-end user layer, Mediagenix applies content and audience intelligence across the entire content chain. By integrating Mediagenix Recommendation into core planning and scheduling tools, customers can act on real-time engagement data to improve performance across:

• Discovery and Curation – Humanized Semantic Search delivers personalized, transparent content results, with Mediagenix reporting up to 23% increased engagement and 35% better conversion.

• Scheduling Automation – Tools such as Scheduling Artist and Smart Content Pool dramatically reduce time-to-air and increase rights usage efficiency, accelerating channel launches by up to 80%.

• Strategic Planning – Web-native planning interfaces improve efficiency by over 30%, allowing teams to align editorial, rights, and platform strategy with predicted audience demand.

“We are honored to be recognized as an IDC Innovator in media and entertainment,” said Fabrice Maquignon, CEO of Mediagenix. “Personalization must be more than a front-end experience. It needs to inform the upstream decisions that determine which content is produced, acquired, and promoted. That’s where real engagement and content profitability are driven.“

Mediagenix solutions were recently honored with multiple awards at the 2025 NAB Show.

For more information about these innovative solutions, please visit https://www.mediagenix.tv/.

*doc #US52275525, May 2025

About IDC Innovators:

An IDC Innovators report presents a set of vendors – under $100M in annual revenue at the time of selection – chosen by an IDC analyst within a specific market that offer a new technology, a groundbreaking solution to an existing issue, and/or an innovative business model. It is not an exhaustive evaluation or a comparative ranking of all companies, but rather a document that highlights innovative companies in a specific market segment. IDC INNOVATOR and IDC INNOVATORS are trademarks of International Data Group, Inc.

About Mediagenix

Mediagenix is a global leader in smart content solutions to profitably connect the right content to the right audience. The Mediagenix modular SaaS platform orchestrates the entire content lifecycle to actively drive content lifetime value and audience engagement. Content strategy, content value management, content scheduling and content personalization all converge into one lean, company-wide collaborative flow revolving around one source of truth. Headquartered in Brussels, Mediagenix has offices in Bangkok, Denver, London, Madrid, Miami, New York City, Paris, Singapore, Skopje, and Sydney. With a team of 400+ experts working closely with 10,000+ users, Mediagenix is the trusted partner for more than 200 media companies globally.

Press Contact

Melissa Harding
Grithaus Agency
(e) melissa@grithaus.agency

SOURCE: Mediagenix

View the original press release on ACCESS Newswire

LAFAYETTE, LA / ACCESS Newswire / July 22, 2025 / Viemed Healthcare, Inc. (the “Company” or “Viemed“) (NASDAQ:VMD), an in-home clinical care provider of post-acute respiratory healthcare equipment and services in the United States, today announced that it will host its Second Quarter 2025 Earnings Conference Call on Thursday, August 7, 2025, at 11:00 a.m. EDT.

Interested parties may participate in the call by dialing:

(877) 407-6176 (US Toll-Free)

+1 (201) 689-8451 (International)

Live Audio Webcast: https://event.choruscall.com/mediaframe/webcast.html?webcastid=4jnXGdPH

Following the live call, a replay will be available in the Investor Relations section of the Company’s website at www.viemed.com.

ABOUT VIEMED HEALTHCARE, INC.

Viemed is an in-home clinical care provider of post-acute respiratory healthcare equipment and services in the United States, including non-invasive ventilators (NIV), sleep therapy, staffing, and other complementary products and services. Viemed focuses on efficient and effective in-home treatment with clinical practitioners providing therapy, education and counseling to patients in their homes using high-touch and high-tech services. Visit our website at www.viemed.com.

For further information, please contact:

Investor Relations
ir@viemed.com

Tripp Sullivan
SCR Partners, LLC
615-942-7077

Trae Fitzgerald
Chief Financial Officer
Viemed Healthcare, Inc.
337-504-3802

SOURCE: Viemed Healthcare, Inc.

View the original press release on ACCESS Newswire

ONTARIO, CA / ACCESS Newswire / July 22, 2025 / Focus Universal Inc. (NASDAQ:FCUV) (“Focus” or the “Company”), a provider of patented hardware and software design technologies for the Internet of Things (IoT), 5G, and SEC Financial Reporting proprietary AI-Driven Automation Software, is pleased to announce that Focus is scheduled begin customer testing of their fully automated SEC financial reporting software on August 30, 2025. The Company also plans to launch a technology roadshow to showcase this groundbreaking platform. Interested clients, partners, corporate filers, and investors are welcome to contact Focus Universal directly at info@focusuniversal.com or ir@focusuniversal.com for meetings and product demonstrations.

SEC financial reporting is traditionally a complex, costly, and time-consuming process. It includes:

• Preparing consolidated financial statements,

• Drafting SEC reports using various office software and / or burdensome company-wide systems,

• Converting those documents into fully SEC-compliant files, and

• Automated embedding of tags as required for regulatory filing.

For large organizations, this process can take thousands of person days. For small public companies, the entire process may take several weeks. Delays in filing can result in SEC reviews, enforcement actions, and significant penalties.

Currently, several companies offer semi-automated solutions that address only part of the tagging process as part of the entire process. Focus Universal, by contrast, has developed a fully automated, end-to-end solution powered by both automation and Variegated AI, whereby Focus believes the technology enables the computer to conduct the activities for which the computer is designed and optimal and allows the human to remain within the decision loop and center upon what the human excels.

With a single click, Focus’ software can:

• Retrieve financial statements from accounting platforms,

• Reformat data into spreadsheets for consolidated financial reporting,

• Automatically generate consolidated financials,

• Populate the word-processed version of SEC filings,

• Convert the documents to SEC-compliant versions via formatting, and

• Automated embedding accurate requisite tags into the HTML file – with very limited manual input.

Built-in validation, including self-consistency and compliance checks, ensures accuracy and eliminates human error. Essentially, Focus believes what once took weeks of manual work can now be completed in minutes.

“I’m extremely proud of what our team has achieved. We sincerely believe this milestone represents a new era for SEC financial reporting,” said Desheng Wang, CEO of Focus Universal. “Unlike other companies offering partial automation, our solution provides a true one-click process from raw accounting data all the way to a complete SEC filing. After years of development, we believe we’ve solved the final challenge – full automated processing including the final edgarization and XBRL tagging.”

According to recent industry analysis, the Financial Reporting Software Market was valued at US $13.9 billion in 2022 and is projected to grow to US $36.6 billion by 2030, at a CAGR of 12.8%. The surge is driven by the increasing complexity of financial data, the high cost of compliance, and the need for scalable, efficient, and intelligent reporting tools. Focus believes this innovation does not replace the SEC-required review process but removes much of the labor-intensive, manual work, dramatically cutting preparation and revision time for public companies. As mentioned, Focus Universal cordially invites investors, industry experts, and public companies to explore potential collaborations or schedule a live demonstration during the upcoming roadshow.

About Focus Universal:
Focus Universal Inc. is a provider of patented hardware and software design technologies for Internet of Things (IoT) and 5G. The company has developed five disruptive patented technology platforms with 26 patents and patents pending in various phases and eight trademarks pending in various phases to solve the major problems facing hardware and software design and production within the industry today. These technologies combined to have the potential to reduce costs, product development timelines and energy usage while increasing range, speed, efficiency, and security. Focus currently trades on the Nasdaq Markets.

Forward-Looking Statements:
Statements in this press release about future expectations, plans and prospects, as well as any other statements regarding matters that are not historical facts, may constitute “forward-looking statements” within the meaning of The Private Securities Litigation Reform Act of 1995. The words “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “potential,” “predict,” “project,” “should,” “target,” “will,” “would” and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors, including: the uncertainties related to market conditions and the completion of the public offering on the anticipated terms or at all, and other factors discussed in the “Risk Factors” section of the preliminary prospectus filed with the SEC. Any forward-looking statements contained in this press release speak only as of the date hereof and Focus Universal specifically disclaims any obligation to update any forward-looking statement, whether because of new information, future events or otherwise.

For company inquiries, please contact:
Investor Relations
626-272-3883
ir@focusuniversal.com

SOURCE: Focus Universal Inc.

View the original press release on ACCESS Newswire

– Video webcast now available on-demand

AURORA, CO / ACCESS Newswire / July 22, 2025 / Exxel Pharma (“Exxel” or the “Company”), a pharmaceutical company dedicated to developing novel therapeutics for the treatment of neuronal hypersensitivity disorders, today announced Soren Mogelsvang PhD, President and Chief Executive Officer and Founder of Exxel, participated in the Virtual Investor “What’s Your Story” Summer Spotlight On-Demand Conference.

As part of the event, Dr. Mogelsvang dove deeper into his dedication to the Company, how he got to where he is today and provided insight into why he is so passionate about the Company’s programs in development.

The on-demand video webcast is now available on virtualinvestorco.com as well as the Events page of the Company’s website (exxelpharma.com).

About Exxel Pharma

Exxel Pharma is a privately held pharmaceutical company dedicated to developing novel therapeutics for the treatment of neuronal hypersensitivity disorders. The Company’s lead program, EX937, is a novel, oral, patented small molecule designed to specifically and peripherally inhibit the fatty acid amide hydrolase (FAAH) enzyme. Exxel plans to launch a first-in-human Phase 1/1b study of EX937 for the treatment of refractory chronic cough, a large underserved market with no current FDA-approved therapies. In preclinical studies, EX937 demonstrated efficacy in its ability to modulate chronic cough in multiple models. Additionally, EX937 has shown to have a favorable preclinical safety profile and is expected to have no CNS side effects by being entirely excluded from the central nervous system and brain. EX937 also has the potential to be utilized across a number of high-value indications, including hyperactive bladder, peripheral neuropathic pain and migraine headaches. Exxel Pharma has a second program (ARN compounds) with the potential to treat Social Anxiety and Autism Spectrum Disorder.

Investor Contact
Jenene Thomas
Chief Executive Officer
JTC Team, LLC
T: 908.824.0775
E: exxel@jtcir.com

SOURCE: Exxel Pharma, Inc.

View the original press release on ACCESS Newswire

– Video webcast now available on-demand

IRVINE, CA / ACCESS Newswire / July 22, 2025 / enVVeno Medical Corporation (NASDAQ:NVNO) (“enVVeno” or the “Company”), a company setting new standards of care for the treatment of deep venous disease, today announced that Rob Berman, CEO of enVVeno, participated in the Virtual Investor “What’s Your Story” Summer Spotlight On-Demand Conference.

As part of the segment, Mr. Berman dove deeper into his dedication to the Company, how he got to where he is today and provided insight into why he is so passionate about the Company’s products in development.

The on-demand video webcast is now available on virtualinvestorco.com as well as the Events page of the enVVeno website, envveno.com.

About enVVeno Medical Corporation
enVVeno Medical (NASDAQ:NVNO) is an Irvine, California-based, late clinical-stage medical device Company focused on the advancement of innovative bioprosthetic (tissue-based) solutions to improve the standard of care for the treatment of deep venous disease. The Company’s lead product, the VenoValve®, is a first-in-class surgical replacement venous valve being developed for the treatment of deep venous Chronic Venous Insufficiency (CVI). The Company is also developing a non-surgical, transcatheter based replacement venous valve for the treatment of deep venous CVI called enVVe®. Both the VenoValve and enVVe are designed to act as one-way valves, to help assist in propelling blood up the leg, and back to the heart and lungs. The VenoValve is currently being evaluated in the VenoValve U.S. pivotal study and the Company is currently performing the final testing necessary to seek approval for the pivotal trial for enVVe.

INVESTOR CONTACT:
Jenene Thomas, JTC Team, LLC
NVNO@jtcir.com
(908) 824-0775

MEDIA CONTACT:
Glenn Silver, FINN Partners
Glenn.Silver@finnpartners.com
(973) 818-8198

SOURCE: enVVeno Medical Corporation

View the original press release on ACCESS Newswire

– Video webcast now available on-demand

MIAMI, FL / ACCESS Newswire / July 22, 2025 / iTolerance, Inc. (“iTolerance” or the “Company”), a biotechnology company focused on the development of innovative regenerative medicines, today announced that Dr. Anthony Japour, Chief Executive Officer of iTolerance, participated in the Virtual Investor “What’s Your Story” Summer Spotlight On-Demand Conference.

As part of the event, Dr. Japour dove deeper into his dedication to the Company, how he got to where he is today and provided insight into why he is so passionate about the Company’s programs in development.

The on-demand video webcast is now available on virtualinvestorco.com as well as the Events page of the Company’s website (itolerance.com).

About iTolerance, Inc.

iTolerance is a regenerative medicine company developing technologies to enable tissue, organoid or cell therapy without requiring life-long immunosuppression. Leveraging its proprietary biotechnology-derived Streptavidin-FasL fusion protein/biotin-PEG microgel (SA-FasL microgel) platform technology, iTOL-100, iTolerance is advancing a pipeline of programs using both allogenic cadaveric and stem cell-derived pancreatic islets to potentially cure Type 1 diabetes. Utilizing iTOL-100 to induce local immune tolerance, the Company is developing its lead indication as a potential cure for Type 1 Diabetes without the need for life-long immunosuppression. Additionally, the Company is developing iTOL-201 for treating liver failure by utilizing hepatocytes and iTOL-401 as a nanoparticle formulation for large organ transplants without the need for life-long immunosuppression. For more information, please visit itolerance.com.

Investor Contact
Jenene Thomas
Chief Executive Officer
JTC Team, LLC
T: 908.824.0775
iTolerance@jtcir.com

Media Contact
Susan Roberts
T:202.779.0929
sr@roberts-communications.com

SOURCE: iTolerance, Inc.

View the original press release on ACCESS Newswire

– Video webcasts from participating companies now available here

FRENCHTOWN, NJ / ACCESS Newswire / July 22, 2025 / JTC Team (“JTC”), a fully integrated corporate communications and investor relations firm, today announced the Virtual Investor “What’s Your Story” Summer Spotlight On-Demand Conference is now live.

For the event, management from the participating companies dove deeper into their dedication to their respective companies, how they got to where they are today and provided insight into why they are so passionate about the products and programs in development.

The video webcasts from participating companies are now available:

• Akari Therapeutics, Plc (NASDAQ:AKTX) – WEBCAST

• Autonomix Medical, Inc. (NASDAQ:AMIX) – WEBCAST

• CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) – WEBCAST

• enVVeno Medical Corporation (NASDAQ:NVNO) – WEBCAST

• Exxel Pharma (Private) – WEBCAST

• GRI Bio, Inc. (NASDAQ:GRI) – WEBCAST

• iTolerance, Inc. (Private) – WEBCAST

• Kaida BioPharma (Private) – WEBCAST

• Moleculin Biotech, Inc. (NASDAQ:MBRX) – WEBCAST

• Nuwellis, Inc. (NASDAQ:NUWE) – WEBCAST

• Outlook Therapeutics, Inc. (NASDAQ:OTLK) – WEBCAST

• Palisade Bio, Inc. (NASDAQ:PALI) – WEBCAST

• Senti Biosciences, Inc. (NASDAQ:SNTI) – WEBCAST

The on-demand presentations are available on the Virtual Investor website, as well as the Investor sections of the respective company websites.

To access all Virtual Investor events, visit www.virtualinvestorco.com.

JTC Team and Virtual Investor Co. are paid consultants to the participating companies. JTC Team and Virtual Investor Co. are investor relations and corporate communications firms. Any content included in this release shall not be construed as an offer to purchase securities of the applicable companies. Interested parties are responsible for conducting their own due diligence and are encouraged to review the companies’ websites and the SEC website for the latest information and filings on each company.

About JTC Team

JTC is a fully integrated investor relations firm that is dedicated to helping you tell your story to the right audiences in order to build awareness. JTC has developed a reputation of excellence for executing on robust communication strategies that deliver results. The Company partners with both public and private companies across the Life Sciences and Technology industries to help raise awareness and build stakeholder value. For more information, please visit www.jtcir.com or connect with the company on X and LinkedIn.

Contact:

Jenene Thomas
JTC Team, LLC
T: +1 (908) 824-0775
jtc@jtcir.com

SOURCE: JTC Team, LLC

View the original press release on ACCESS Newswire

Formation of Treasury Subsidiary Marks Strategic Expansion as GENIUS Act Spurs Acceleration of SMX’s Blockchain and Digital Asset Vision

NEW YORK, NY / ACCESS Newswire / July 22, 2025 / At SMX (Security Matters) (NASDAQ:SMX), we’ve spent years building the infrastructure to bring traceability, trust, and transparency to global supply chains. We didn’t wait for regulation to validate our vision-we built ahead of it. Now, with the recent signing of the GENIUS Act into U.S. law, our strategic roadmap is no longer just pioneering-it’s perfectly positioned.

The GENIUS Act represents a historic milestone: the first comprehensive federal framework recognizing cryptocurrency and stablecoins in the world’s largest economy. For SMX, this legislation doesn’t prompt a pivot-it acts as an immediate accelerator to our long-standing digital asset strategy.

As the next step in this progression, and as announced in a Form 6-K filing, SMX shall establish a new, wholly owned subsidiary in Ireland: SMX (Treasury and Digital Asset Holding Company) Limited. This new entity enables us to incorporate Bitcoin and other digital assets into our treasury operations, designed to protect value and mirror the same digital backbone that powers our core innovations.

This isn’t a reaction to changing policy. It’s the continuation of our strategic mission – now aligned with a global regulatory shift toward digital economies.

Our technology, including the Plastic Cycle Token (PCT), is already built on blockchain to provide verifiable, auditable tracking of materials from origin to end use. The PCT will offer brands a way to tangibly monetize circularity and meet global compliance standards through a secure, decentralized ledger. What others are now scrambling to create, we’ve already launched.

The GENIUS Act, along with an expected follow-on bill anticipated this week, provides a more favorable environment for scaling these systems efficiently and legally. These laws don’t change our mission; they fast-track it.

SMX was created to lead in a world where digital trust, material accountability, and decentralized verification would define commerce. That world is now here. And with this latest evolution of our treasury operations, we’re not just prepared-we’re leading.

About SMX (Security Matters) Public Limited Company
As global businesses face new and complex challenges relating to carbon neutrality and meeting new governmental and regional regulations and standards, SMX is able to offer players along the value chain access to its marking, tracking, measuring and digital platform technology to transition more successfully to a low-carbon economy.

Forward-Looking Statements
The information in this press release includes “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include, but are not limited to, statements regarding expectations, hopes, beliefs, intentions or strategies regarding the future. In addition, any statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. The words “anticipate,” “believe,” “contemplate,” “continue,” “could,” “estimate,” “expect,” “forecast,” “intends,” “may,” “will,” “might,” “plan,” “possible,” “potential,” “predict,” “project,” “should,” “would” and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. Forward-looking statements in this press release may include, for example: matters relating to the Company’s fight against abusive and possibly illegal trading tactics against the Company’s stock; successful launch and implementation of SMX’s joint projects with manufacturers and other supply chain participants of steel, rubber and other materials; changes in SMX’s strategy, future operations, financial position, estimated revenues and losses, projected costs, prospects and plans; SMX’s ability to develop and launch new products and services, including its planned Plastic Cycle Token; SMX’s ability to successfully and efficiently integrate future expansion plans and opportunities; SMX’s ability to grow its business in a cost-effective manner; SMX’s product development timeline and estimated research and development costs; the implementation, market acceptance and success of SMX’s business model; developments and projections relating to SMX’s competitors and industry; and SMX’s approach and goals with respect to technology. These forward-looking statements are based on information available as of the date of this press release, and current expectations, forecasts and assumptions, and involve a number of judgments, risks and uncertainties. Accordingly, forward-looking statements should not be relied upon as representing views as of any subsequent date, and no obligation is undertaken to update forward-looking statements to reflect events or circumstances after the date they were made, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws. As a result of a number of known and unknown risks and uncertainties, actual results or performance may be materially different from those expressed or implied by these forward-looking statements. Some factors that could cause actual results to differ include: the ability to maintain the listing of the Company’s shares on Nasdaq; changes in applicable laws or regulations; any lingering effects of the COVID-19 pandemic on SMX’s business; the ability to implement business plans, forecasts, and other expectations, and identify and realize additional opportunities; the risk of downturns and the possibility of rapid change in the highly competitive industry in which SMX operates; the risk that SMX and its current and future collaborators are unable to successfully develop and commercialize SMX’s products or services, or experience significant delays in doing so; the risk that the Company may never achieve or sustain profitability; the risk that the Company will need to raise additional capital to execute its business plan, which may not be available on acceptable terms or at all; the risk that the Company experiences difficulties in managing its growth and expanding operations; the risk that third-party suppliers and manufacturers are not able to fully and timely meet their obligations; the risk that SMX is unable to secure or protect its intellectual property; the possibility that SMX may be adversely affected by other economic, business, and/or competitive factors; and other risks and uncertainties described in SMX’s filings from time to time with the Securities and Exchange Commission.

Media Contact For This Release:
info@hawkpointmedia.com

SOURCE: SMX (Security Matters) Public Limited

View the original press release on ACCESS Newswire

Innovative Compression Molding Enables Complex Designs, Embedded Features, and Material Integration for OEMs Across Industries

MADISON, SD / ACCESS Newswire / July 22, 2025 / Global Polymer Industries, a leader in advanced polymer solutions, is transforming what OEMs can expect from ultra-high molecular weight polyethylene (UHMW-PE). With proprietary custom molding capabilities, Global Polymer Industries now delivers net-shape molded UHMW-PE components that go far beyond traditional performance, offering unmatched durability, resistance, and design flexibility for demanding industrial applications.

Unlike standard UHMW-PE sheets that require machining after production, Global Polymer’s compression molding technology forms parts to near-final shape from the outset. This unlocks a new world of manufacturing possibilities for OEMs looking to eliminate secondary processing, reduce costs, and improve part precision.

Key advantages of Global Polymer’s custom molding process include:

• Complex geometries with varying wall thicknesses in a single part

• Molded-in logos, part numbers, or tracking features

• Integration of additional materials, such as metal inserts, screws, or supports

• The self-lubricating, impact-resistant, and low-friction benefits of UHMW-PE, customized for any end-use application

“We’re not just shaping plastic-we’re shaping the future of manufacturing,” said Derek Mertz, Engineering R&D Manager at Global Polymer. “With our custom molding technology, OEMs gain design freedom that sheet-based UHMW-PE simply can’t provide, like variable thicknesses, molded-in part features, and integrated fasteners.”

Global Polymer serves a wide range of industries, from forestry and food processing to wastewater, agriculture, and material handling, where component reliability, speed, and performance are mission-critical. By leveraging its unique compression molding process, the company helps OEMs streamline production, extend part life, and eliminate failure points caused by bolted or welded assemblies.

To learn more about how custom-molded UHMW-PE can elevate your supply chain and production process, visit www.globalpolymer.com.

About Global Polymer Industries

Global Polymer is an industry leader in custom-molded UHMW-PE (Ultra High Molecular Weight Polyethylene) components, delivering innovative solutions to some of the world’s most demanding industries. From forestry and food processing to marine, mining, transportation, and manufacturing, Global Polymer partners with OEMs and manufacturers to engineer high-performance parts that stand up to wear, corrosion, and extreme environments. With a relentless focus on quality, precision, and customer collaboration, Global Polymer helps companies extend equipment life and improve efficiency. Learn more at www.globalpolymer.com.

Media Contact:
Global Polymer
Phone: (605) 256-3150
Website: www.globalpolymer.com
Email: Emily Sorenson – emilys@henkinschultz.com

SOURCE: Global Polymer Industries

View the original press release on ACCESS Newswire

NORTH YORK, ON / ACCESS Newswire / July 22, 2025 / ZTEST Electronics Inc. (“ZTEST” or the “Company“) (CSE:ZTE)(OTCID:ZTSTF) is pleased to announce it has entered into an agreement dated July 22, 2025 (the “Agreement”) with Integral Wealth Securities Limited (“Integral”) to provide market-making services in compliance with the policies and guidelines of the Canadian Securities Exchange and other applicable legislation. The objectives of the services to be provided by Integral are to call a two-sided market; contribute to market liquidity and depth of the Company’s common shares; and maintain activity in the market.

The Company and Integral are unrelated and unaffiliated entities. Integral and its clients may acquire an interest in the securities of the Company in the future. Integral will be responsible for the costs it incurs in buying and selling the Company’s common shares, and no third party will be providing funds or securities for the market making activities.

Headquartered in Toronto, Integral is a national independent CIRO-licensed investment dealer, with recognised proficiencies in market making, wealth management and investment banking. The firm’s FINRA-regulated US broker dealer affiliate, Integral Wealth Securities LLC, is involved in investment banking and private placements.

About ZTEST Electronics Inc.
ZTEST Electronics Inc., through its wholly owned subsidiary Permatech Electronics Corporation (“Permatech”), offers Electronic Manufacturing Services (EMS) to a wide range of customers. Permatech’s offering includes Printed Circuit Board (PCB) Assembly, Materials Management and Testing services. Permatech operates from an ISO 9001:2015 certified facility in North York, Ontario, Canada. Permatech is a contract assembler of complex circuit boards, serving customers in the Medical, Power, Computer, Telecommunications, Wireless, Industrial, Trucking, Wearables and Consumer Electronics markets. It specializes in servicing customers who are looking for high yield and require high quality and rapid-turnaround on low and mid-volume production of high complexity products.

For more information contact: Steve Smith, CEO (604) 837-3751 email: steves@ztest.com

Neither the Canadian Securities Exchange nor its Market Regulator (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

FORWARD-LOOKING STATEMENTS: This press release contains forward-looking statements, which relate to future events or future performance and reflect management’s current expectations and assumptions. Such forward-looking statements reflect management’s current beliefs and are based on assumptions made by and information currently available to the Company. Investors are cautioned that these forward-looking statements are neither promises nor guarantees and are subject to risks and uncertainties that may cause future results to differ materially from those expected. These forward-looking statements are made as of the date hereof and, except as required under applicable securities legislation, the Company does not assume any obligation to update or revise them to reflect new events or circumstances. All of the forward-looking statements made in this press release are qualified by these cautionary statements and by those made in our filings with SEDAR+ in Canada (available at www.sedarplus.com).

SOURCE: ZTEST Electronics Inc.

View the original press release on ACCESS Newswire